PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli 35053, Taiwan.\', \'National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli 35053, Taiwan; Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan; Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.\', \'Department of Food Science, National Taiwan Ocean University, Keelung 20224, Taiwan.\', \'National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli 35053, Taiwan; Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan; Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. Electronic address: huangminghsi@nhri.edu.tw.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0378-5173(21)00830-910.1016/j.ijpharm.2021.121024
?:hasPublicationType
?:journal
  • International journal of pharmaceutics
is ?:pmid of
?:pmid
?:pmid
  • 34416331
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.172
?:rankingScore_hIndex
  • 179
is ?:relation_isRelatedTo_publication of
?:title
  • Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all